NF-κB drives epithelial-mesenchymal mechanisms of lung fibrosis in a translational lung cell model
Authors:
- Patrick SieberPSPatrick Sieber
- Anny SchäferASAnny Schäfer
- Raphael LieberherrRLRaphael Lieberherr
- Silvia L. CaimiSCSilvia L. Caimi
- Urs LüthiULUrs Lüthi
- Jesper RygeJRJesper Ryge
- Jan H. BergmannJBJan H. Bergmann
- Manuel StrittMSManuel Stritt
- Peter BlattmannPBPeter Blattmann
- Bérengère RenaultBRBérengère Renault
- Patrick RammeltPRPatrick Rammelt
Open Access
- 8 February 2023
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 8 (3)
Abstract
In the progression phase of idiopathic pulmonary fibrosis (IPF), the normal alveolar structure of the lung is lost and replaced by remodeled fibrotic tissue and by bronchiolized cystic airspaces. Although these are characteristic features of IPF, knowledge of specific interactions between these pathological processes is limited. Here, the interaction of lung epithelial and lung mesenchymal cells was investigated in a coculture model of human primary airway epithelial cells (EC) and lung fibroblasts (FB). Single-cell RNA sequencing revealed that the starting EC population was heterogenous and enriched for cells with a basal cell signature. Furthermore, fractions of the initial EC and FB populations adopted distinct pro-fibrotic cell differentiation states upon cocultivation, resembling specific cell populations that were previously identified in lungs of patients with IPF. Transcriptomic analysis revealed active NF-κB signaling early in the cocultured EC and FB, and the identified NF-κB expression signatures were found in “HAS1 High FB” and “PLIN2+ FB” populations from IPF patient lungs. Pharmacological blockade of NF-κB signaling attenuated specific phenotypic changes of EC and prevented FB-mediated interleukin-6, interleukin-8, and CXC chemokine ligand 6 cytokine secretion, as well as collagen α-1(I) chain and α–smooth muscle actin accumulation. Thus, we identified NF-κB as a potential mediator, linking epithelial pathobiology with fibrogenesis.Keywords
Funding Information
- Idorsia Pharmaceuticals (not applicable)
This publication has 51 references indexed in Scilit:
- Type 2 alveolar cells are stem cells in adult lungJournal of Clinical Investigation, 2013
- The role of semaphorins and their receptors in vascular development and cancerExperimental Cell Research, 2013
- Enrichr: interactive and collaborative HTML5 gene list enrichment analysis toolBMC Bioinformatics, 2013
- The Idiopathic Pulmonary Fibrosis Honeycomb Cyst Contains A Mucocilary Pseudostratified EpitheliumPLOS ONE, 2013
- Epithelial Cells as Active Player In Fibrosis: Findings from an In Vitro ModelPLOS ONE, 2013
- Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertensionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1Proceedings of the National Academy of Sciences, 2008
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- Novel Inhibitors of Cytokine-induced IκBα Phosphorylation and Endothelial Cell Adhesion Molecule Expression Show Anti-inflammatory Effects in VivoJournal of Biological Chemistry, 1997